We continue to focus on stocks that are showing relative strength and absolute price momentum. This week we're looking sticking with a sector that continues to work, Pharma.
Last week we retired our "Five Bull Market Barometers" to make room for a new weekly post that's focused on the three most important charts for the week ahead.
This is our first edition, so let's jump right into it.
Welcome to this week's edition of "Under The Hood." You can read more about the column here.
What we do is analyze the most popular Robinhood stocks over the trailing week and find opportunities to either join in and ride these momentum names higher, or fade the crowd and bet against them.
This week we have a handful of trade ideas on the long side, many of which belong to the Health Care space and are working on Covid-19 vaccines.
We'll also walk through a number of mega-cap bellwethers and get a feel for what's going on in that space.
The stock market has been going crazy again this week, and maybe it's beginning to rub off on me... We usually only share about 10 charts in this post, but there is just too much going on in these names so I went a little crazy myself in looking through the charts for this week's post. We ended up with 14. Let's dive into it!
Here is this week's list of most popular stocks, measured by net increases in Robinhood accounts that hold shares.
Another quick little update on the NKLA position we put on a couple weeks ago.
Our patience from our original entry timing has paid off, and the directional move we were playing for has happened. $NKLA has traded down to our target price of $35.
JC's been pounding the table to me about Abbott Labs $ABT for a couple weeks now.
I've been slow playing it, waiting for some new highs. We're getting them now. It's time to get involved.
The base $ABT formed over the last three months is a thing of beauty. And the fact that it's in a hot sector and printing new all-time highs is only sweetener. Then when you add in the fact that options premiums are at the lowest levels since March and I'm starting to get pretty excited.
I don't prefer getting long stocks that aren't breaking through to some kind of major new high or an all-time high. But every so often the stars align to play for the end of a major downtrend with some clearly defined levels of support to lean against.
We're finding that right now in the recently maligned Marijuana stocks space.